These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26947026)

  • 1. Cyclophosphamide therapy for secondary amyloidosis in a patient with juvenile idiopathic arthritis unresponsive to tumor necrosis factor α inhibitor therapy.
    Han SA; Yoon YM; Lee WS; Kim YS; Shin BC; Chung JH; Kim HL
    Korean J Intern Med; 2016 May; 31(3):601-4. PubMed ID: 26947026
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid and complete resolution of ascites and hydrothorax due to nephrotic syndrome caused by renal amyloidosis in a patient with juvenile chronic arthritis treated with adalimumab.
    Nowak B; Jeka S; Wiland P; Szechiński J
    Joint Bone Spine; 2009 Mar; 76(2):217-9. PubMed ID: 19196533
    [No Abstract]   [Full Text] [Related]  

  • 3. Disseminated Tuberculosis Resulting From Reinfection in a Pediatric Patient Sequentially Treated With Etanercept and Adalimumab.
    Guerrero-Laleona C; Calzada-Hernández J; Bustillo-Alonso M; Gil-Albarova J; Medrano-San Ildefonso M; Iglesias-Jiménez E; Noguera-Julian A
    Pediatr Infect Dis J; 2017 Jan; 36(1):109-110. PubMed ID: 27749657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-adalimumab antibodies in juvenile idiopathic arthritis: frequent association with loss of response.
    Skrabl-Baumgartner A; Erwa W; Muntean W; Jahnel J
    Scand J Rheumatol; 2015; 44(5):359-62. PubMed ID: 25974288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L44. Management of relapses in vasculitis.
    Mouthon L
    Presse Med; 2013 Apr; 42(4 Pt 2):619-22. PubMed ID: 23477710
    [No Abstract]   [Full Text] [Related]  

  • 6. The impact of disease activity and tumour necrosis factor-α inhibitor therapy on cytokine levels in juvenile idiopathic arthritis.
    Walters HM; Pan N; Lehman TJ; Adams A; Kalliolias GD; Zhu YS; Santiago F; Nguyen J; Sitaras L; Cunningham-Rundles S; Walsh TJ; Toussi SS
    Clin Exp Immunol; 2016 Jun; 184(3):308-17. PubMed ID: 26934060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adalimumab-Induced Cutaneous Lupus Erythematosus in a 16-Year-Old Girl with Juvenile Idiopathic Arthritis.
    West ES; Nanda K; Ofodile O; Rutledge J; Brandling-Bennett HA
    Pediatr Dermatol; 2015; 32(4):e140-4. PubMed ID: 25845414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Antiinflammatory Treatment on the Onset of Uveitis in Juvenile Idiopathic Arthritis: Longitudinal Analysis From a Nationwide Pediatric Rheumatology Database.
    Tappeiner C; Schenck S; Niewerth M; Heiligenhaus A; Minden K; Klotsche J
    Arthritis Care Res (Hoboken); 2016 Jan; 68(1):46-54. PubMed ID: 26212111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of uveitis associated with juvenile idiopathic arthritis.
    Bou R; Iglesias E; Antón J
    Curr Rheumatol Rep; 2014 Aug; 16(8):437. PubMed ID: 24938442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective anti-TNF-alpha therapy can induce rapid resolution and sustained decrease of gastroduodenal mucosal amyloid deposits in reactive amyloidosis associated with rheumatoid arthritis.
    Kuroda T; Wada Y; Kobayashi D; Murakami S; Sakai T; Hirose S; Tanabe N; Saeki T; Nakano M; Narita I
    J Rheumatol; 2009 Nov; 36(11):2409-15. PubMed ID: 19797512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful use of tocilizumab in amyloidosis secondary to systemic juvenile idiopathic arthritis.
    Gupta A; Bagri NK; Tripathy SK; Barwad A; Phulware RH; Hari P
    Rheumatol Int; 2020 Jan; 40(1):153-159. PubMed ID: 31273457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which patients with rheumatoid arthritis, spondyloarthritis, or juvenile idiopathic arthritis receive TNF-α antagonists in France? The CORPUS cohort study.
    Saraux A; Benichou J; Guillevin L; Idbrik L; Job-Deslandre C; Sibilia J; Soudant M; Wendling D; Guillemin F
    Clin Exp Rheumatol; 2015; 33(5):602-10. PubMed ID: 26315585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-interleukin 1 treatment in secondary amyloidosis associated with autoinflammatory diseases.
    Topaloglu R; Batu ED; Orhan D; Ozen S; Besbas N
    Pediatr Nephrol; 2016 Apr; 31(4):633-40. PubMed ID: 26563115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term evaluation of cardiac function in juvenile idiopathic arthritis under anti-TNF therapy.
    Lianza AC; Aikawa NE; Moraes JC; Leal GN; Morhy SS; Andrade JL; Bonfa E; Silva CA
    Clin Exp Rheumatol; 2014; 32(5):754-9. PubMed ID: 25152021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermatomyositis induced by anti-tumor necrosis factor in a patient with juvenile idiopathic arthritis.
    Liu SW; Velez NF; Lam C; Femia A; Granter SR; Townsend HB; Vleugels RA
    JAMA Dermatol; 2013 Oct; 149(10):1204-8. PubMed ID: 23986394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canakinumab for the treatment of systemic juvenile idiopathic arthritis.
    Grom AA
    Expert Rev Clin Immunol; 2014 Nov; 10(11):1427-35. PubMed ID: 25269376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment with anti-tumor necrosis factor alpha for reactive small-bowel amyloidosis.
    Lee CK; Park JY; Shim JJ; Jang JY
    Endoscopy; 2011; 43 Suppl 2 UCTN():E326-7. PubMed ID: 22020709
    [No Abstract]   [Full Text] [Related]  

  • 18. Profile of adalimumab and its potential in the treatment of uveitis.
    Balevic SJ; Rabinovich CE
    Drug Des Devel Ther; 2016; 10():2997-3003. PubMed ID: 27698552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced levels of circulating progenitor cells in juvenile idiopathic arthritis are counteracted by anti TNF-α therapy.
    Martini G; Biscaro F; Boscaro E; Calabrese F; Lunardi F; Facco M; Agostini C; Zulian F; Fadini GP
    BMC Musculoskelet Disord; 2015 Apr; 16():103. PubMed ID: 25925313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the use of Anti-TNFα therapy for the treatment of juvenile idiopathic arthritis.
    Taddio A; Cattalini M; Simonini G; Cimaz R
    Expert Rev Clin Immunol; 2016 Jun; 12(6):641-9. PubMed ID: 26809126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.